Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders Life Science Investing
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections Life Science Investing
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences Life Science Investing
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference Life Science Investing
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors Life Science Investing
C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma Life Science Investing
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference Life Science Investing
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer Life Science Investing
Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Life Science Investing
Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
